Hong Kong Winhealth Pharma Group

Winhealth is a China-based, Asia Pacific centric, innovative biotechnology company, providing novel breakthrough therapies to patients with rare diseases and other unmet medical needs. Winhealth primarily focused on licensing in novel breakthrough therapies from leading global biopharma companies, to serve patients with rare diseases and other unmet medical needs in the region. The company is headquartered in Hong Kong, with operating hubs in Hangzhou, Shanghai, and Beijing. The company owns Chinas first rare disease managed access platform in Boao, Hainan. The company also has representative offices in Japan, Singapore and Europe. Winhealth has built a unique, balanced and diversified portfolio...

罕见病,专科疾病,肝胆消化,呼吸抗感染,皮肤医美,创新疗法,男女性健康,and 心脑血管

Hong kong winhealth pharma group operates in the Pharmaceutical manufacturing industry.

Hong kong winhealth pharma group's revenue is 11m - 100m

Hong kong winhealth pharma group has 11 - 50 employees.